Melita Sun Jung - 30 Jan 2025 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role: Chief Business Officer
Signature: /s/ David Strauss, as Attorney-in-Fact for Melita Sun Jung
Issuer symbol: TERN
Transactions as of: 30 Jan 2025
Net transactions value: +$11,498
Form type: 4
Filing time: 03 Feb 2025, 19:28:43 UTC
Previous filing: 02 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TERN	Common Stock	Purchase	$11,498	+2,250		$5.11	2,250	30 Nov 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TERN	Stock Option (Right to Buy)	Award	$0	+325,000		$0.000000	325,000	30 Jan 2025	Common Stock	325,000	$4.64	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 2,250 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on November 30, 2024.
F2	25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.